Download PDF 

Characteristics
Morphology
Polio virus is the type species of the Enterovirus genus in the family Picornaviridae. Enteroviruses are transient inhabitants of the gastrointestinal tract, and are stable at an acidic pH. Picornaviruses are small with an RNA genome. There are three poliovirus serotypes (P1, P2, and P3). Immunity to one serotype does not produce immunity to the other serotypes.
Disease
Poliomyelitis, polioencephalitis
Zoonosis
Poliovirus only infects humans.
Health Hazards
Host Range
Humans. No endogenous reservoir exist in the United States.
Modes of Transmission
Person to person transmission can occur through fecal oral route and via infected feces and body fluids. Contact precautions should be used. Note that alcohol-based hand sanitizers do not kill poliovirus.
Signs and Symptoms
Polio invades the nervous system, and can cause total paralysis in a matter of hours. The virus enters the body through the mouth and multiplies in the intestine. Initial symptoms of polio include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. In a small proportion of cases, the disease causes paralysis, which is often permanent.
Polioencephalitis is rare and generally occurs in infants. Between 25-50% of survivors may develop postpolio syndrome experienced over their remaining life as muscle weakness and extreme fatigue.
Infectious Dose
Unknown
Incubation Period
9-12 days
Medical Precautions/Treatment
Prophylaxis
Vaccination.
Vaccines
If potential exposure, check antibody to Polio. A positive antibody indicates protection.
IPV – Inactivated polio vaccine recommended if no antibody.
OPV – Oral Polio vaccine- No longer distributed in the United States
Treatment
There is no specific treatment for polio. Persons infected with polio need supportive therapy, such as bed rest and fluids. Severe paralytic disease impacting diaphragm may require mechanical ventilation.
Surveillance
Polioviruses usually can be isolated from throat secretions in the first week of illness and from feces, often for several weeks. In the absence of a viral isolate, the diagnosis of poliovirus infection can be established serologically by testing paired acute and convalescent sera for neutralizing antibodies to each of the three poliovirus serotypes. Serologic tests cannot distinguish between wild-type virus and vaccine virus infection. These viruses can be detected by PCR.
MSU Requirements
Report any potential exposures.
Laboratory Hazards
Laboratory Acquired Infections (LAIs)
Many potential LAIs in vaccine production facilities.
Sources
Cultures, frozen stocks, other samples described in IBC protocol.
Supplemental References
Canadian MSDS:
n/a
BMBL
CDC
NIH Guidelines
Risk Group & containment Requirements
Risk Group 2
Agents that are associated with human disease which is rarely serious and for which preventive or
therapeutic interventions are often available.
BSL2
For all procedures involving suspected or known infectious specimen or cultures.
ABSL2
For all procedures utilizing infected animals.
Spill Procedures
Small
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill with absorbent material and add fresh 1:10 bleach:water. Allow 20 minutes (or as directed) of contact time. After 20 minutes, cleanup and dispose of materials.
Large
• Immediately notify all personnel in the lab and clear all personnel from the area. Remove any contaminated PPE/clothing and leave the lab.
• Secure the area by locking doors, posting signage and guarding the area to keep people out of the space.
For assistance, contact MSU's Biosafety Officer (406-994-6733) or Safety and Risk Management (406-994-2711).
Exposure Procedures
Mucous membrane
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
Other Exposures
Wash area with soap and water for 5 minutes.
Reporting
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
Medical Follow-up

During business hours:
Bridger Occupational Health 3406 Laramie Drive Weekdays 8am -6pm. Weekends 9am-5pm

After business hours:
Bozeman Deaconess Hospital Emergency Room
915 Highland Blvd

Viability
Disinfection
0.5% bleach solution is recommended disinfectant.
Inactivation
Polio virus is resistant to inactivation by common laboratory disinfectants such as alcohol. The virus is rapidly destroyed by exposure to temperatures of 50°C or more, autoclaving or incineration. It is readily inactivated by dilute solutions of formaldehyde, bleach.
Survival Outside Host
Polio virus is very stable at an acidic pH and can remain infectious for long periods of time in food and water.
Personal Protective Equipment (PPE)
Minimum PPE Requirements
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
Additional Precautions
Additional PPE may be required depending on lab specific SOPs and IBC Protocol.